Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Gao

Showing results (1491-1500 of 1,578) with videos related to

Pageof 158
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 11, 2023
First-in-human evaluation of a novel ultrathin sirolimus-eluting iron bioresorbable scaffold: 3-year outcomes of the IBS-FIM trialRun-Lin Gao, Bo Xu, Zhongwei Sun, et al.
Nature|August 9, 2023
Mitochondrial integrated stress response controls lung epithelial cell fateSeungHye Han, Minho Lee, Youngjin Shin, et al.
Chinese Medical Journal|October 3, 2020
Clinical characteristics of early and late drug-eluting stent in-stent restenosis and mid-term prognosis after repeated percutaneous coronary interventionJian-Feng Zheng, Ting-Ting Guo, Yuan Tian, et al.
Chinese Medical Journal|January 23, 2008
Effects of sirolimus-eluting stent on calcified coronary lesionsJian-jun Li, Bo Xu, Yue-jin Yang, et al.
Chinese Medical Journal|April 19, 2007
Age-based clinical and angiographic outcomes after sirolimus-eluting stent implantation in patients with coronary artery diseaseBo Xu, Jian-jun Li, Yue-jin Yang, et al.
Chinese Medical Journal|July 13, 2006
A comparison of angiographic and clinical outcomes after sirolimus-eluting versus paclitaxel-eluting stents for the treatment of in-stent restenosisJian-jun Li, Bo Xu, Yue-jin Yang, et al.
Chinese Medical Journal|April 27, 2011
A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up resultsBo Xu, Ke-fei Dou, Ya-ling Han, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Metal impurities cause false positives in high-throughput screening campaignsJohannes C Hermann, Yingsi Chen, Charles Wartchow, et al.
Chinese Medical Journal|May 6, 2011
Comparison of long-term clinical outcome after successful implantation of FIREBIRD and CYPHER sirolimus-eluting stents in daily clinical practice: analysis of a large single-center registryBo Xu, Ke-Fei Dou, Yue-Jin Yang, et al.
Experimental Biology and Medicine (Maywood, N.J.)|July 10, 2014
Inhibition of EZH2 expression is associated with the proliferation, apoptosis, and migration of SW620 colorectal cancer cells in vitroSong-Bing He, Hao Zhou, Jian Zhou, et al.
Pageof 158

Showing results (1491-1500 of 1,578) with videos related to

Sort By:
Pageof 158
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 11, 2023
First-in-human evaluation of a novel ultrathin sirolimus-eluting iron bioresorbable scaffold: 3-year outcomes of the IBS-FIM trialRun-Lin Gao, Bo Xu, Zhongwei Sun, et al.
Nature|August 9, 2023
Mitochondrial integrated stress response controls lung epithelial cell fateSeungHye Han, Minho Lee, Youngjin Shin, et al.
Chinese Medical Journal|October 3, 2020
Clinical characteristics of early and late drug-eluting stent in-stent restenosis and mid-term prognosis after repeated percutaneous coronary interventionJian-Feng Zheng, Ting-Ting Guo, Yuan Tian, et al.
Chinese Medical Journal|January 23, 2008
Effects of sirolimus-eluting stent on calcified coronary lesionsJian-jun Li, Bo Xu, Yue-jin Yang, et al.
Chinese Medical Journal|April 19, 2007
Age-based clinical and angiographic outcomes after sirolimus-eluting stent implantation in patients with coronary artery diseaseBo Xu, Jian-jun Li, Yue-jin Yang, et al.
Chinese Medical Journal|July 13, 2006
A comparison of angiographic and clinical outcomes after sirolimus-eluting versus paclitaxel-eluting stents for the treatment of in-stent restenosisJian-jun Li, Bo Xu, Yue-jin Yang, et al.
Chinese Medical Journal|April 27, 2011
A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up resultsBo Xu, Ke-fei Dou, Ya-ling Han, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Metal impurities cause false positives in high-throughput screening campaignsJohannes C Hermann, Yingsi Chen, Charles Wartchow, et al.
Chinese Medical Journal|May 6, 2011
Comparison of long-term clinical outcome after successful implantation of FIREBIRD and CYPHER sirolimus-eluting stents in daily clinical practice: analysis of a large single-center registryBo Xu, Ke-Fei Dou, Yue-Jin Yang, et al.
Experimental Biology and Medicine (Maywood, N.J.)|July 10, 2014
Inhibition of EZH2 expression is associated with the proliferation, apoptosis, and migration of SW620 colorectal cancer cells in vitroSong-Bing He, Hao Zhou, Jian Zhou, et al.
Pageof 158